Drugs / recombinant HIV-1 Tat protein
recombinant HIV-1 Tat protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00505401 | Dec 2003 → Nov 2007 | HIV infectious disease | Italian National Institute of Health | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant HIV-1 Tat protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00505401 ↗ |
| Modality | Protein / enzyme biologic | “biologically active Tat protein” NCT00505401 ↗ |
| Route | Subcutaneous | “Subjects were immunized subcutaneously with Tat” NCT00505401 ↗ |